OCS
Oculis Holding AG Ordinary shares
NASDAQ: OCS · HEALTHCARE · BIOTECHNOLOGY
$27.48
+3.89% today
Updated 2026-04-30
Market cap
$1.57B
P/E ratio
—
P/S ratio
1,311.54x
EPS (TTM)
$-2.40
Dividend yield
—
52W range
$16 – $31
Volume
0.4M
Oculis Holding AG Ordinary shares (OCS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $16.38M | $58.04M | $37.06M | $114.35M | $120.35M |
| Cash & equivalents | $4.95M | $46.28M | $19.79M | $38.33M | $27.71M |
| Current assets | $6.16M | $47.98M | $23.66M | $101.02M | $104.90M |
| Total liabilities | $60.04M | $119.00M | $135.05M | $20.63M | $46.97M |
| Current liabilities | $4.34M | $4.06M | $12.02M | $19.09M | $44.23M |
| Long-term debt | $53.98M | $113.50M | $122.45M | — | — |
| Shareholder equity | $-43.65M | $-60.95M | $-97.99M | $93.73M | $73.38M |
| Retained earnings | $-53.73M | $-72.28M | $-110.98M | $-199.78M | $-285.56M |
| Accounts receivable | $1.14M | $911000.00 | $1.08M | $7.95M | $777000.00 |
| Inventory | $72000.00 | $-911000.00 | $-1.08M | $-1.20M | — |
| Goodwill | — | — | — | — | — |